408 related items for PubMed ID: 11793859
21. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Hamed RM.
J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
[Abstract] [Full Text] [Related]
22. Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.
Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M.
Nephrol Dial Transplant; 2005 Apr; 20(4):735-42. PubMed ID: 15772265
[Abstract] [Full Text] [Related]
23. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up.
Li J, Zhang YM, Qu Z, Zhao MH, Liu G.
Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650
[Abstract] [Full Text] [Related]
24. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C, Li H, Wen YB, Li JN, Lin WF, Cai JF, Duan L, Li Y, Li XM, Li XW.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug 20; 39(4):544-551. PubMed ID: 28877834
[Abstract] [Full Text] [Related]
25. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P, Koutroulia E, Sotsiou F, Vlachojannis JG, Goumenos DS.
Nephrology (Carlton); 2010 Dec 20; 15(8):762-7. PubMed ID: 21175962
[Abstract] [Full Text] [Related]
26. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
Rostoker G, Ben Maadi A, Remy P, Lang P, Lagrue G, Weil B.
Nephrol Dial Transplant; 1995 Dec 20; 10(1):25-9. PubMed ID: 7724024
[Abstract] [Full Text] [Related]
27. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
Nephrol Dial Transplant; 2005 May 20; 20(5):968-73. PubMed ID: 15741208
[Abstract] [Full Text] [Related]
28. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
Polanco N, Gutiérrez E, Rivera F, Castellanos I, Baltar J, Lorenzo D, Praga M, Grupo de Estudio de las Enfermedades Glomerulares de la Sociedad Española de Nefrología (GLOSEN).
Nephrol Dial Transplant; 2012 Jan 20; 27(1):231-4. PubMed ID: 21624942
[Abstract] [Full Text] [Related]
29. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
Peng LK, Xie XB, Peng FH, Wang Y, Jiang Y, Lan GB, Fang CH, Nie MH.
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 20; 32(1):59-62. PubMed ID: 17344588
[Abstract] [Full Text] [Related]
30. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM, Deegens JK, Willems HL, Wetzels JF.
Nephrol Dial Transplant; 2008 Aug 20; 23(8):2546-51. PubMed ID: 18308774
[Abstract] [Full Text] [Related]
31. Initial remission-inducing effect of very low-dose cyclosporin monotherapy for minimal-change nephrotic syndrome in Japanese adults.
Matsumoto H, Nakao T, Okada T, Nagaoka Y, Shino T, Yoshino M, Hidaka H.
Clin Nephrol; 2001 Feb 20; 55(2):143-8. PubMed ID: 11269678
[Abstract] [Full Text] [Related]
32. Long-term outcome of patients with idiopathic membranous nephropathy.
Ríhová Z, Merta M, Maixnerová D, Honsová E, Reiterová J, Rysavá R, Zabka J, Tesar V.
Prague Med Rep; 2006 Feb 20; 107(2):189-98. PubMed ID: 17066739
[Abstract] [Full Text] [Related]
33. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, Pasquali S, Imbasciati E, Grassi C, Redaelli B.
N Engl J Med; 1989 Jan 05; 320(1):8-13. PubMed ID: 2642605
[Abstract] [Full Text] [Related]
34. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
Kosmadakis G, Filiopoulos V, Smirloglou D, Skarlas P, Georgoulias C, Michail S.
Ren Fail; 2010 Jun 05; 32(5):566-71. PubMed ID: 20486839
[Abstract] [Full Text] [Related]
35. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
Clin Nephrol; 1999 Aug 05; 52(2):67-75. PubMed ID: 10480216
[Abstract] [Full Text] [Related]
36. Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands.
Hofstra JM, Wetzels JF.
Nephrol Dial Transplant; 2008 Nov 05; 23(11):3534-8. PubMed ID: 18559961
[Abstract] [Full Text] [Related]
37. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
[Abstract] [Full Text] [Related]
38. Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen.
Hassan K, Kristal B.
Minerva Urol Nefrol; 2016 Jun 15; 68(3):293-301. PubMed ID: 25645342
[Abstract] [Full Text] [Related]
39. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
Am J Kidney Dis; 2003 Jan 15; 41(1):38-48. PubMed ID: 12500220
[Abstract] [Full Text] [Related]
40. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS, Kalliakmani P, Tsakas S, Sotsiou F, Vlachojannis JG.
Clin Nephrol; 2004 Jan 15; 61(1):17-24. PubMed ID: 14964453
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
